Cargando…
Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels
BACKGROUND: In chronic hepatitis B virus (HBV) patients, fluctuations in HBV DNA serve as a “gray area” and impede the accurate identification of inactive carriers. We aimed to assess if such fluctuations impact the presence of significant hepatic fibrosis (Metavir F2-4) in chronic HBV patients. MET...
Autores principales: | Sanai, Faisal M., Alhouthali, Ahmad H., Alghamdi, Hamdan S., Badriq, Feras, Sanai, Eisa A., Mujalled, Mohammed K., Khayyat, Waleed, Attar, Motaz S., Bagadeem, Basil S., Meer, Alaa M., Alshumrani, Waleed, Albeladi, Khalid, AlTraif, Ibrahim, Alqahtani, Saleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752532/ https://www.ncbi.nlm.nih.gov/pubmed/35488588 http://dx.doi.org/10.4103/sjg.sjg_48_22 |
Ejemplares similares
-
Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia
por: Sanai, Faisal M., et al.
Publicado: (2019) -
Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
por: Sanai, Faisal M., et al.
Publicado: (2017) -
Correlation Between Hepatitis B Surface Antigen Titers and HBV DNA Levels
por: Alghamdi, Amal, et al.
Publicado: (2013) -
Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
por: Ahmed, Fatima A., et al.
Publicado: (2019) -
SASLT Practice Guidelines: Management of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)